The enigmatic haemorrhagic fevers

Journal of the Royal Society of Medicine

Volumn 90, Issue 11, 1997, Pages 622-624

  Suresh, V ^a   Card, D ^a  

^a Tata Tea Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE; HEMORRHAGIC FEVER; LASSA FEVER; SHORT SURVEY; VIRUS HEMORRHAGIC FEVER; YELLOW FEVER;

EID: 0030779237     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689709001108     Document Type: Short Survey

References (24)

1. Cahill KM, O'Brien W. Viral infection in the tropics. In: Tropical Medicine, a Clinical Text, 3rd edn. Oxford; Heinemann Medical, 1990:102-11
2. WHO. Prevention and control of Yellow Fever in Africa, Geneva: 1986:1
3. Boocken G, Barros MLB. Jungle yellow lover in the central Amazon. Lancet 1996;348:969-70
4. Halstead SB. The 20th century dengue pandemic: need for surveillance and research. World Health Stat Q. 1992;45:292-8
5. WHO. Dengue Haemorrhage Fever: Diagnosis, Treatment and Control. Geneva: WHO, 1986:7
6. Rodhain F. Recent data on epidemiology of dengue fever. Bull Acad Natl Med 1992; 34:350-7
7. Suleiman MNEH, Muscat-Baron JM, Harries JR, et al. Crimean Congo haemorrhagic fever in Dubai. Lancet 1980;ii:939-41
8. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo haemorrhagic lever treated with oral ribavirin, Lancet 1995;346:472-5
9. Welsby PD. Viral haemorrhagic levers. In: Hall AP, ed. Notes on Infectious Diseases. Edinburgh: Churchill Livingstone, 1982:231-6
10. WHO. International Nomenclature of Diseases. Geneva: WHO, 1981:75
11. McCormick JB, King IJ, Wohb PA, et al. Lassa fever, effective therapy with rihavirin. N Engl J Med 1986;314 :20-6
12. Fisher-Hoch SP, Craven RB, Forthall DN, et al. Sale intensive care management of a severe case of Lassa lever with simple harrier nursing techniques. Lanect 1985;ii:1227-9
13. Holmes GP, McCormick JB, Trod SC, et al. Lassa lever in the united States. N Engl J Med 1990;323:1120-3
14. Johnson KM, Monath TP. Imported Lassa fever - reexamining the algorithms. N Engl J Med 1990;323:1139-41
15. Maiztegui JI, Fernandez NJ, de Damilano AJ. Efficacy of immune plasma in treatment of Argentinian haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 1979;ii:216-17
16. Yanagihara R. Hanta virus infection in the United States, epizootology and epidemiology. Rev Infect Dis 1990;12:449-57
17. Anon, Ebola virus infection. BMJ 1977;ii:539-40
18. Bowen FTW, Platt CJS, Lloyd G, Baskerville A, Harris WJ, Vella EE. Viral haemorrhagic fever in southern Sudan and northern Zaire. Lancet 1977;ii:571-3
19. Johnson KM, Webb PA, Lange JV, Murphy FA. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1977;ii:569-71
20. Dyer O. Ebola threat eases. BMJ 1995;310:1553
21. Bennet D, Brown IX. Ehola virus, BMJ 1995;310:1344-5
22. Update-managcment of patients with suspected viral haemorrhage fever - United States. JAMA 1995;274:374-5
23. LeDuc JW, Tkhomirov E. Global surveillance for recognition and response to emerging diseases. Ann NY Acad Sci 1994;740:341-5
24. John JJ. Emerging and re-emerging threats to human health. Natl Med J Ind 1996;9:1-2